| IPO Listing At | NSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹56.87 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹56.87 Cr |
| Fresh Issue | ₹31.02 Cr |
| Offer for Sale | ₹22.99 Cr |
| Face Value | ₹10 Per Equity Share |
| Issue Price | ₹121.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | QMSMEDI |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | First Overseas Capital Ltd. |
| Allotment Status |
| DRHP |
| RHP |
| Final Prospectus |
![]() ₹0 A/C OpeningFree MF ₹20F&O Trade ₹0Delivery 1Cr+Customers Open Free Account → |
![]() ₹0 A/C Opening₹0 AMC Trading Account ₹20F&O Trade ₹20Delivery FreeIPO Apply Open Free Account → |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,000 shares and in multiples thereof
Incorporated in 2017, QMS Medical Allied Services Limited is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and they also manage the distribution for other brands such as 3M, Heine, Rossmax etc.
The company offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
The company also aims to impact the lives of people through continuous skill development and hence provides various medical courses like PG Diploma in Cardiology, Masterclass in Diabetes & renel management, cardiology and cardiac rehabilitation etc. for continuous skill development.
The company markets and help in the distribution of the products across India through offline and online mode using the website i.e. https://qmsmas.com. The company's eCommerce platform is called Qmeds- https://qmsmeds.com, which provides online service to medical equipment dealers, distributors, surgeons and clinicians for sourcing medical supplies from the surgical supply store.
Competitive Strength :
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding additional working capital requirements | 27.00 |
| 2 | General Corporate Purposes | 6.58 |
| Period Ended | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|
| Assets | 82.67 | 60.37 | 33.48 |
| Total Income | 147.75 | 122.09 | 72.78 |
| Profit After Tax | 10.71 | 10.92 | 6.35 |
| NET Worth | 31.03 | 20.32 | 9.41 |
| Reserves and Surplus | 27.27 | 16.56 | 6.40 |
| Amount in ₹ Crore | |||
| KPI | |
|---|---|
| Debt / Equity | 1.03% |
| RoNW | 34.5% |
| PAT Margin | 7.25% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 7.11 | |
| P/E (x) | 20.1 | |
| Promoter Holding | 100% | 73.67% |
| Market Cap | ₹215.99 Cr. | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Payment to Merchant Banker including, underwriting, and selling commissions, brokerages, Advisors to the Company, payment to other intermediaries such as Legal Advisors, Registrars etc. and other out of pocket expenses, Brokerage and selling commission | 0.36 |
| 2 | Advertising and marketing expenses | 0.05 |
| 3 | Printing and stationery expenses, distribution, and postage | 0.03 |
| 4 | ROC, Regulatory and other expenses including Listing Fee | 0.06 |
Last Updated on 26-Jun-2026 18:10:12